NAP1L1 and hepatocellular carcinoma: Survival analysis showed that overexpressed NAP1L1 is an unfavorable factor, reducing the overall survival time of HCC patients (Figure 1H), and then the clinical significance of NAP1L1 expression was assessed (Table 1).